CanSino Biologics Ramps Up Vaccine Production During Phase III Trials

September 28, 2020

CanSino Biologics Ramps Up Vaccine Production During Phase III Trials

Chinese company CanSino Biologics Inc has plans to ramp up production of their COVID-19 vaccine following the completion of Phase III clinical trials. The company plans to produce 300 million doses a year. Yourway has a 11,700 square foot local depot located in Beijing, China and has capacity globally to help facilitate clinical trials anywhere.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Schedule a Meeting

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Schedule a Meeting

Media

Articles

Keeping trials on track: Prioritizing communication in decentralized trials

Open chat

Hello! How can I help you?